Dr. Robert J. Behrens
Claim this profileIowa Methodist Medical Center
Studies Breast Cancer
Studies Breast cancer
43 reported clinical trials
97 drugs studied
About Robert J. Behrens
Education:
- Graduated with a BS in Chemistry, with distinction, from Iowa State University, 1992.
- Earned an MD from the University of Iowa College of Medicine, 1997.
Experience:
- Completed Residency in Internal Medicine at Johns Hopkins University / Sinai Hospital, 2000.
- Fellowship in immuno-therapy of cancer at the National Cancer Institute, 2003.
- Joined Mission Cancer + Blood in 2003, with board certifications in Medical Oncology, Hematology, and Internal Medicine.
- Actively involved in national cancer vaccine trials and serves at multiple medical centers.
Area of expertise
1Breast Cancer
HER2 positive
Stage II
HER2 negative
2Breast Cancer
HER2 positive
Stage III
ER negative
Affiliated Hospitals
Clinical Trials Robert J. Behrens is currently running
Chemotherapy + Radiotherapy
for Esophageal and Gastric Cancer
This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy x-rays, gamma rays, or protons to kill tumor cells and shrink tumors. Drugs used in usual chemotherapy, such as leucovorin, 5-fluorouracil, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding radiotherapy to the usual chemotherapy may work better compared to the usual chemotherapy alone in treating patients with esophageal and gastric cancer.
Recruiting2 awards Phase 320 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Robert J. Behrens
Clinical Trial Related5 years of experience running clinical trials · Led 43 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Robert J. Behrens has experience with
- Paclitaxel
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Fluorouracil
- Radiation Therapy
- Trastuzumab
Breakdown of trials Robert J. Behrens has run
Breast Cancer
Breast cancer
Prostate Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert J. Behrens specialize in?
Robert J. Behrens focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage II.
Is Robert J. Behrens currently recruiting for clinical trials?
Yes, Robert J. Behrens is currently recruiting for 15 clinical trials in Des Moines Iowa. If you're interested in participating, you should apply.
Are there any treatments that Robert J. Behrens has studied deeply?
Yes, Robert J. Behrens has studied treatments such as Paclitaxel, Cisplatin, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Robert J. Behrens?
Apply for one of the trials that Robert J. Behrens is conducting.
What is the office address of Robert J. Behrens?
The office of Robert J. Behrens is located at: Iowa Methodist Medical Center, Des Moines, Iowa 50309 United States. This is the address for their practice at the Iowa Methodist Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.